Framework contract for in vivo studies on NB-PDX models in mice

Summary

Charité - Universitätsmedizin Berlin announces a framework agreement for in vivo studies on NB-PDX models in mice. The studies may include therapy, characterization, or biodistribution/pharmacokinetics studies and collection of PDX tumor material. This is a framework contract with a single contractor; detailed requirements and BerlAVG-specific provisions apply and are described in the tender documents.